Mental retardation cost-effectiveness of therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Mental retardation}} | {{Mental retardation}} | ||
{{CMG}} {{AE}}{{Chelsea}} | |||
== References == | ==Overview== | ||
{{ | |||
==Cost-effectiveness of Therapy== | |||
==References== | |||
{{Reflist|2}} | |||
{{WH}} | {{WH}} | ||
{{WS}} | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Psychiatry]] | [[Category:Psychiatry]] | ||
[[Category:Disability]] | [[Category:Disability]] |
Latest revision as of 01:06, 7 July 2021
Mental retardation Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mental retardation cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Mental retardation cost-effectiveness of therapy |
Mental retardation cost-effectiveness of therapy in the news |
Risk calculators and risk factors for Mental retardation cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Chelsea Mae Nobleza, M.D.[2]